Streetbeat News

Insider Trading

ALZN

CMRX

NTWK

Insiders at Alzamend Neuro, Chimerix, and NetSol Technologies have recently purchased shares in their respective companies. Alzamend Neuro's CFO acquired 53,000 shares at an average price of $0.19, following the company's submission of an investigational new drug application to the FDA. Chimerix's Director bought 20,000 shares at an average price of $0.98 after the company posted a narrower-than-expected Q2 loss. NetSol Technologies' CEO purchased 10,000 shares at an average price of $1.88, despite the company posting a wider loss for Q4.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 1:15 pm

HSY

SCS

Insiders at Zscaler, Inc. (NASDAQ:ZS), Steelcase Inc. (NYSE:SCS), The Hershey Company (NYSE:HSY), and Helmerich & Payne, Inc. (NYSE:HP) have recently sold shares. While insider sales can sometimes indicate concern about a company's prospects or overpricing, they can also be preplanned and should not be the sole indicator for investment decisions.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 11:54 am

LFVN

MDRR

MPAA

TLYS

Insiders have recently purchased shares in four companies: Motorcar Parts of America, LifeVantage, Tilly's, and Medalist Diversified REIT. This could indicate confidence in the companies' prospects or that the insiders view the stocks as bargains. However, insider purchases should not be the sole indicator for making investment or trading decisions.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 10:32 am

ARS

ARS Pharmaceuticals Director Rajeev Shah has acquired a total of 2,700,000 shares at an average price of $3.03, amounting to roughly $8.18 million. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 2:08 pm

CXDO

KIRK

SOL

SPRY

Insiders at ARS Pharmaceuticals, Crexendo, Emeren Group, and Kirkland's have recently made significant purchases of their companies' stocks. ARS Pharmaceuticals' director acquired 2.7 million shares for around $8.18 million, following the FDA's response to their New Drug Application. Crexendo's director bought 5,000 shares after the company posted positive Q2 results. Emeren Group's director purchased 437,258 shares after the company reported better-than-expected quarterly earnings. Kirkland's interim CEO bought 3,978 shares following weaker-than-expected Q2 FY23 results.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 12:53 pm

LSCC

SLB

SPLK

TTOO

Insiders at Lattice Semiconductor Corporation (LSCC), Splunk Inc. (SPLK), Schlumberger Limited (SLB), and T2 Biosystems, Inc. (TTOO) have recently sold shares. While insider sales can sometimes indicate concern about a company's prospects, they can also be part of a preplanned sale. Rosenblatt reiterated LSCC with a Buy and maintained a $110 price target. Cisco announced it will acquire SPLK for roughly $28 billion. Citigroup maintained SLB with a Buy and raised the price target from $66 to $70. The FDA cleared TTOO's biothreat panel for commercial distribution.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 12:09 pm

ADC

DLTR

SWX

Insiders at Southwest Gas Holdings, Inc. (SWX), Dollar Tree, Inc. (DLTR), and Agree Realty Corporation (ADC) have recently made notable purchases of their companies' stocks. This could indicate their confidence in the companies' prospects. Southwest Gas posted better-than-expected Q2 earnings, Dollar Tree reported better-than-expected earnings and sales for Q2, and Agree Realty promoted Nicole Witteveen to COO.

Portfolio Pulse from Lisa Levin

September 26, 2023 | 10:58 am

PFSW

Beryl Capital Management LLC has increased its stake in PFSweb to 9.9%, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 8:20 pm

TTOO

T2 Biosystems, Inc. (NASDAQ:TTOO) shares are trading lower, with a drop of over 50% in the last five days. This follows a large insider sale of TTOO shares by CR Group, L.P., who sold more than 10 million shares at $0.366 per share. Despite the FDA clearing the company's biothreat panel for commercial distribution, the stock has attracted attention from retail investors and short-sellers.

Portfolio Pulse from Erica Kollmann

September 25, 2023 | 4:47 pm

AAPL

AMZN

BIIB

DLAKY

GOOG

NVS

PFE

RNAZ

TSN

WMT

Several significant business events have occurred. Ford of Canada has reached a collective agreement with Unifor union, including wage increases and pension improvements. Amazon has invested $4 billion in AI startup Anthropic. PhonePe, backed by Walmart, has launched the Indus AppStore Developer Platform to challenge Google's dominance in India. Goodyear plans to redefine its operational presence in the Asia Pacific region. Pfizer's RSVpreF vaccine has been recommended by the CDC for pregnant people. Mercedes Benz has partnered with Mastercard to introduce in-car digital payments. Novartis plans to spin-off the Sandoz business. Eisai and Biogen's Alzheimer treatment Leqembi has been approved in Japan. Alcoa has appointed William F. Oplinger as President and CEO. TransCode Therapeutics' stock is trading higher after positive results with its therapeutic candidate, TTX-MC138. Tyson Foods and Perdue Farms are under investigation over alleged child labor violations. OpenAI has unveiled a new feature for its ChatGPT application, enabling verbal responses. Apple's iOS 17 update allows users to opt for a search engine other than Google. Austrian Airlines faced backlash for making inaccurate environmental claims.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 2:58 pm